世界のタイプAボツリヌス毒素市場2022年:50U、100U、その他

◆英語タイトル:Global Type A Botulinum Toxin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書(GIR22MY8980)◆商品コード:GIR22MY8980
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2022年5月(※2025年版があります。お問い合わせください。)
◆ページ数:93
◆レポート形式:英語 / PDF
◆納品方法:Eメール(注文後2-3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

タイプAボツリヌス毒素市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のタイプAボツリヌス毒素の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

タイプAボツリヌス毒素市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・50U、100U、その他

用途別セグメントは次のように区分されます。
・毒免疫、モノクローナル抗体

世界のタイプAボツリヌス毒素市場の主要な市場プレーヤーは以下のとおりです。
・ALLERGAN、Roche、Pfizer、Galderma、Merz Pharma、DAEWOONG、Ipsen、Sinopharm

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、タイプAボツリヌス毒素製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なタイプAボツリヌス毒素メーカーの企業概要、2019年~2022年までのタイプAボツリヌス毒素の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なタイプAボツリヌス毒素メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別タイプAボツリヌス毒素の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までのタイプAボツリヌス毒素の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域でのタイプAボツリヌス毒素市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびタイプAボツリヌス毒素の産業チェーンを掲載しています。
・第13、14、15章では、タイプAボツリヌス毒素の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):ALLERGAN、Roche、Pfizer、Galderma、Merz Pharma、DAEWOONG、Ipsen、Sinopharm
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:50U、100U、その他
・用途別分析2017年-2028年:毒免疫、モノクローナル抗体
・タイプAボツリヌス毒素の北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ
・タイプAボツリヌス毒素のヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア
・タイプAボツリヌス毒素のアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア
・タイプAボツリヌス毒素の南米市場規模2017年-2028年:ブラジル、アルゼンチン
・タイプAボツリヌス毒素の中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Type A Botulinum Toxin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Type A Botulinum Toxin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Poison Immune accounting for % of the Type A Botulinum Toxin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 50U segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Type A Botulinum Toxin include ALLERGAN, Roche, Pfizer, Galderma, and Merz Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Type A Botulinum Toxin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
50U
100U
Other
Market segment by Application can be divided into
Poison Immune
Monoclonal Antibody
The key market players for global Type A Botulinum Toxin market are listed below:
ALLERGAN
Roche
Pfizer
Galderma
Merz Pharma
DAEWOONG
Ipsen
Sinopharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Type A Botulinum Toxin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Type A Botulinum Toxin, with price, sales, revenue and global market share of Type A Botulinum Toxin from 2019 to 2022.
Chapter 3, the Type A Botulinum Toxin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Type A Botulinum Toxin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Type A Botulinum Toxin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Type A Botulinum Toxin.
Chapter 13, 14, and 15, to describe Type A Botulinum Toxin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Type A Botulinum Toxin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Type A Botulinum Toxin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 50U
1.2.3 100U
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Type A Botulinum Toxin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Poison Immune
1.3.3 Monoclonal Antibody
1.4 Global Type A Botulinum Toxin Market Size & Forecast
1.4.1 Global Type A Botulinum Toxin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Type A Botulinum Toxin Sales in Volume (2017-2028)
1.4.3 Global Type A Botulinum Toxin Price (2017-2028)
1.5 Global Type A Botulinum Toxin Production Capacity Analysis
1.5.1 Global Type A Botulinum Toxin Total Production Capacity (2017-2028)
1.5.2 Global Type A Botulinum Toxin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Type A Botulinum Toxin Market Drivers
1.6.2 Type A Botulinum Toxin Market Restraints
1.6.3 Type A Botulinum Toxin Trends Analysis
2 Manufacturers Profiles
2.1 ALLERGAN
2.1.1 ALLERGAN Details
2.1.2 ALLERGAN Major Business
2.1.3 ALLERGAN Type A Botulinum Toxin Product and Services
2.1.4 ALLERGAN Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Type A Botulinum Toxin Product and Services
2.2.4 Roche Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Type A Botulinum Toxin Product and Services
2.3.4 Pfizer Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Galderma
2.4.1 Galderma Details
2.4.2 Galderma Major Business
2.4.3 Galderma Type A Botulinum Toxin Product and Services
2.4.4 Galderma Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merz Pharma
2.5.1 Merz Pharma Details
2.5.2 Merz Pharma Major Business
2.5.3 Merz Pharma Type A Botulinum Toxin Product and Services
2.5.4 Merz Pharma Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 DAEWOONG
2.6.1 DAEWOONG Details
2.6.2 DAEWOONG Major Business
2.6.3 DAEWOONG Type A Botulinum Toxin Product and Services
2.6.4 DAEWOONG Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Ipsen
2.7.1 Ipsen Details
2.7.2 Ipsen Major Business
2.7.3 Ipsen Type A Botulinum Toxin Product and Services
2.7.4 Ipsen Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sinopharm
2.8.1 Sinopharm Details
2.8.2 Sinopharm Major Business
2.8.3 Sinopharm Type A Botulinum Toxin Product and Services
2.8.4 Sinopharm Type A Botulinum Toxin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Type A Botulinum Toxin Breakdown Data by Manufacturer
3.1 Global Type A Botulinum Toxin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Type A Botulinum Toxin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Type A Botulinum Toxin
3.4 Market Concentration Rate
3.4.1 Top 3 Type A Botulinum Toxin Manufacturer Market Share in 2021
3.4.2 Top 6 Type A Botulinum Toxin Manufacturer Market Share in 2021
3.5 Global Type A Botulinum Toxin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Type A Botulinum Toxin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Type A Botulinum Toxin Market Size by Region
4.1.1 Global Type A Botulinum Toxin Sales in Volume by Region (2017-2028)
4.1.2 Global Type A Botulinum Toxin Revenue by Region (2017-2028)
4.2 North America Type A Botulinum Toxin Revenue (2017-2028)
4.3 Europe Type A Botulinum Toxin Revenue (2017-2028)
4.4 Asia-Pacific Type A Botulinum Toxin Revenue (2017-2028)
4.5 South America Type A Botulinum Toxin Revenue (2017-2028)
4.6 Middle East and Africa Type A Botulinum Toxin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Type A Botulinum Toxin Sales in Volume by Type (2017-2028)
5.2 Global Type A Botulinum Toxin Revenue by Type (2017-2028)
5.3 Global Type A Botulinum Toxin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Type A Botulinum Toxin Sales in Volume by Application (2017-2028)
6.2 Global Type A Botulinum Toxin Revenue by Application (2017-2028)
6.3 Global Type A Botulinum Toxin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Type A Botulinum Toxin Sales by Type (2017-2028)
7.2 North America Type A Botulinum Toxin Sales by Application (2017-2028)
7.3 North America Type A Botulinum Toxin Market Size by Country
7.3.1 North America Type A Botulinum Toxin Sales in Volume by Country (2017-2028)
7.3.2 North America Type A Botulinum Toxin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Type A Botulinum Toxin Sales by Type (2017-2028)
8.2 Europe Type A Botulinum Toxin Sales by Application (2017-2028)
8.3 Europe Type A Botulinum Toxin Market Size by Country
8.3.1 Europe Type A Botulinum Toxin Sales in Volume by Country (2017-2028)
8.3.2 Europe Type A Botulinum Toxin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Type A Botulinum Toxin Sales by Type (2017-2028)
9.2 Asia-Pacific Type A Botulinum Toxin Sales by Application (2017-2028)
9.3 Asia-Pacific Type A Botulinum Toxin Market Size by Region
9.3.1 Asia-Pacific Type A Botulinum Toxin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Type A Botulinum Toxin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Type A Botulinum Toxin Sales by Type (2017-2028)
10.2 South America Type A Botulinum Toxin Sales by Application (2017-2028)
10.3 South America Type A Botulinum Toxin Market Size by Country
10.3.1 South America Type A Botulinum Toxin Sales in Volume by Country (2017-2028)
10.3.2 South America Type A Botulinum Toxin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Type A Botulinum Toxin Sales by Type (2017-2028)
11.2 Middle East & Africa Type A Botulinum Toxin Sales by Application (2017-2028)
11.3 Middle East & Africa Type A Botulinum Toxin Market Size by Country
11.3.1 Middle East & Africa Type A Botulinum Toxin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Type A Botulinum Toxin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Type A Botulinum Toxin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Type A Botulinum Toxin
12.3 Type A Botulinum Toxin Production Process
12.4 Type A Botulinum Toxin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Type A Botulinum Toxin Typical Distributors
13.3 Type A Botulinum Toxin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Type A Botulinum Toxin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Type A Botulinum Toxin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ALLERGAN Basic Information, Manufacturing Base and Competitors
Table 4. ALLERGAN Major Business
Table 5. ALLERGAN Type A Botulinum Toxin Product and Services
Table 6. ALLERGAN Type A Botulinum Toxin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Major Business
Table 9. Roche Type A Botulinum Toxin Product and Services
Table 10. Roche Type A Botulinum Toxin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Type A Botulinum Toxin Product and Services
Table 14. Pfizer Type A Botulinum Toxin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Galderma Basic Information, Manufacturing Base and Competitors
Table 16. Galderma Major Business
Table 17. Galderma Type A Botulinum Toxin Product and Services
Table 18. Galderma Type A Botulinum Toxin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merz Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Merz Pharma Major Business
Table 21. Merz Pharma Type A Botulinum Toxin Product and Services
Table 22. Merz Pharma Type A Botulinum Toxin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. DAEWOONG Basic Information, Manufacturing Base and Competitors
Table 24. DAEWOONG Major Business
Table 25. DAEWOONG Type A Botulinum Toxin Product and Services
Table 26. DAEWOONG Type A Botulinum Toxin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Ipsen Basic Information, Manufacturing Base and Competitors
Table 28. Ipsen Major Business
Table 29. Ipsen Type A Botulinum Toxin Product and Services
Table 30. Ipsen Type A Botulinum Toxin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sinopharm Basic Information, Manufacturing Base and Competitors
Table 32. Sinopharm Major Business
Table 33. Sinopharm Type A Botulinum Toxin Product and Services
Table 34. Sinopharm Type A Botulinum Toxin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Type A Botulinum Toxin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Type A Botulinum Toxin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Type A Botulinum Toxin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Type A Botulinum Toxin Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Type A Botulinum Toxin Production Site of Key Manufacturer
Table 40. Type A Botulinum Toxin New Entrant and Capacity Expansion Plans
Table 41. Type A Botulinum Toxin Mergers & Acquisitions in the Past Five Years
Table 42. Global Type A Botulinum Toxin Sales by Region (2017-2022) & (K Units)
Table 43. Global Type A Botulinum Toxin Sales by Region (2023-2028) & (K Units)
Table 44. Global Type A Botulinum Toxin Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Type A Botulinum Toxin Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Type A Botulinum Toxin Sales by Type (2017-2022) & (K Units)
Table 47. Global Type A Botulinum Toxin Sales by Type (2023-2028) & (K Units)
Table 48. Global Type A Botulinum Toxin Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Type A Botulinum Toxin Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Type A Botulinum Toxin Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Type A Botulinum Toxin Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Type A Botulinum Toxin Sales by Application (2017-2022) & (K Units)
Table 53. Global Type A Botulinum Toxin Sales by Application (2023-2028) & (K Units)
Table 54. Global Type A Botulinum Toxin Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Type A Botulinum Toxin Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Type A Botulinum Toxin Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Type A Botulinum Toxin Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Type A Botulinum Toxin Sales by Country (2017-2022) & (K Units)
Table 59. North America Type A Botulinum Toxin Sales by Country (2023-2028) & (K Units)
Table 60. North America Type A Botulinum Toxin Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Type A Botulinum Toxin Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Type A Botulinum Toxin Sales by Type (2017-2022) & (K Units)
Table 63. North America Type A Botulinum Toxin Sales by Type (2023-2028) & (K Units)
Table 64. North America Type A Botulinum Toxin Sales by Application (2017-2022) & (K Units)
Table 65. North America Type A Botulinum Toxin Sales by Application (2023-2028) & (K Units)
Table 66. Europe Type A Botulinum Toxin Sales by Country (2017-2022) & (K Units)
Table 67. Europe Type A Botulinum Toxin Sales by Country (2023-2028) & (K Units)
Table 68. Europe Type A Botulinum Toxin Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Type A Botulinum Toxin Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Type A Botulinum Toxin Sales by Type (2017-2022) & (K Units)
Table 71. Europe Type A Botulinum Toxin Sales by Type (2023-2028) & (K Units)
Table 72. Europe Type A Botulinum Toxin Sales by Application (2017-2022) & (K Units)
Table 73. Europe Type A Botulinum Toxin Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Type A Botulinum Toxin Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Type A Botulinum Toxin Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Type A Botulinum Toxin Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Type A Botulinum Toxin Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Type A Botulinum Toxin Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Type A Botulinum Toxin Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Type A Botulinum Toxin Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Type A Botulinum Toxin Sales by Application (2023-2028) & (K Units)
Table 82. South America Type A Botulinum Toxin Sales by Country (2017-2022) & (K Units)
Table 83. South America Type A Botulinum Toxin Sales by Country (2023-2028) & (K Units)
Table 84. South America Type A Botulinum Toxin Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Type A Botulinum Toxin Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Type A Botulinum Toxin Sales by Type (2017-2022) & (K Units)
Table 87. South America Type A Botulinum Toxin Sales by Type (2023-2028) & (K Units)
Table 88. South America Type A Botulinum Toxin Sales by Application (2017-2022) & (K Units)
Table 89. South America Type A Botulinum Toxin Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Type A Botulinum Toxin Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Type A Botulinum Toxin Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Type A Botulinum Toxin Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Type A Botulinum Toxin Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Type A Botulinum Toxin Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Type A Botulinum Toxin Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Type A Botulinum Toxin Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Type A Botulinum Toxin Sales by Application (2023-2028) & (K Units)
Table 98. Type A Botulinum Toxin Raw Material
Table 99. Key Manufacturers of Type A Botulinum Toxin Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Type A Botulinum Toxin Typical Distributors
Table 103. Type A Botulinum Toxin Typical Customers
List of Figures
Figure 1. Type A Botulinum Toxin Picture
Figure 2. Global Type A Botulinum Toxin Revenue Market Share by Type in 2021
Figure 3. 50U
Figure 4. 100U
Figure 5. Other
Figure 6. Global Type A Botulinum Toxin Revenue Market Share by Application in 2021
Figure 7. Poison Immune
Figure 8. Monoclonal Antibody
Figure 9. Global Type A Botulinum Toxin Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Type A Botulinum Toxin Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Type A Botulinum Toxin Sales (2017-2028) & (K Units)
Figure 12. Global Type A Botulinum Toxin Price (2017-2028) & (US$/Unit)
Figure 13. Global Type A Botulinum Toxin Production Capacity (2017-2028) & (K Units)
Figure 14. Global Type A Botulinum Toxin Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Type A Botulinum Toxin Market Drivers
Figure 16. Type A Botulinum Toxin Market Restraints
Figure 17. Type A Botulinum Toxin Market Trends
Figure 18. Global Type A Botulinum Toxin Sales Market Share by Manufacturer in 2021
Figure 19. Global Type A Botulinum Toxin Revenue Market Share by Manufacturer in 2021
Figure 20. Type A Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Type A Botulinum Toxin Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Type A Botulinum Toxin Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Type A Botulinum Toxin Sales Market Share by Region (2017-2028)
Figure 24. Global Type A Botulinum Toxin Revenue Market Share by Region (2017-2028)
Figure 25. North America Type A Botulinum Toxin Revenue (2017-2028) & (USD Million)
Figure 26. Europe Type A Botulinum Toxin Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Type A Botulinum Toxin Revenue (2017-2028) & (USD Million)
Figure 28. South America Type A Botulinum Toxin Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Type A Botulinum Toxin Revenue (2017-2028) & (USD Million)
Figure 30. Global Type A Botulinum Toxin Sales Market Share by Type (2017-2028)
Figure 31. Global Type A Botulinum Toxin Revenue Market Share by Type (2017-2028)
Figure 32. Global Type A Botulinum Toxin Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Type A Botulinum Toxin Sales Market Share by Application (2017-2028)
Figure 34. Global Type A Botulinum Toxin Revenue Market Share by Application (2017-2028)
Figure 35. Global Type A Botulinum Toxin Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Type A Botulinum Toxin Sales Market Share by Type (2017-2028)
Figure 37. North America Type A Botulinum Toxin Sales Market Share by Application (2017-2028)
Figure 38. North America Type A Botulinum Toxin Sales Market Share by Country (2017-2028)
Figure 39. North America Type A Botulinum Toxin Revenue Market Share by Country (2017-2028)
Figure 40. United States Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Type A Botulinum Toxin Sales Market Share by Type (2017-2028)
Figure 44. Europe Type A Botulinum Toxin Sales Market Share by Application (2017-2028)
Figure 45. Europe Type A Botulinum Toxin Sales Market Share by Country (2017-2028)
Figure 46. Europe Type A Botulinum Toxin Revenue Market Share by Country (2017-2028)
Figure 47. Germany Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Type A Botulinum Toxin Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Type A Botulinum Toxin Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Type A Botulinum Toxin Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Type A Botulinum Toxin Revenue Market Share by Region (2017-2028)
Figure 56. China Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Type A Botulinum Toxin Sales Market Share by Type (2017-2028)
Figure 63. South America Type A Botulinum Toxin Sales Market Share by Application (2017-2028)
Figure 64. South America Type A Botulinum Toxin Sales Market Share by Country (2017-2028)
Figure 65. South America Type A Botulinum Toxin Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Type A Botulinum Toxin Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Type A Botulinum Toxin Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Type A Botulinum Toxin Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Type A Botulinum Toxin Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Type A Botulinum Toxin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Type A Botulinum Toxin in 2021
Figure 77. Manufacturing Process Analysis of Type A Botulinum Toxin
Figure 78. Type A Botulinum Toxin Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のタイプAボツリヌス毒素市場2022年:50U、100U、その他(Global Type A Botulinum Toxin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。